Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Archives of Surgery (Chicago, Ill. : 1960)|December 24, 1997
Splenic abscess: another look at an old diseaseG S Phillips, M D Radosevich, P A Lipsett
Gastroenterology|February 1, 1991
Neuromodulation of guinea pig intestinal electrolyte transport by cholecystokinin octapeptideJ F Kachur, G S Phillips, T S Gaginella
Journal of Veterinary Internal Medicine|March 4, 2017
Urethral Sphincter Mechanism Incompetence in 163 Neutered Female Dogs: Diagnosis, Treatment, and Relationship of Weight and Age at Neuter to Development of DiseaseJ K Byron, K H Taylor, G S Phillips, et al.
The Journal of Family Practice|January 1, 1995
A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytologyE J Mayeaux, M B Harper, F Abreo, et al.
Bone Marrow Transplantation|November 25, 2014
Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCTE N Amin, G S Phillips, P Elder, et al.
Thyroid : Official Journal of the American Thyroid Association|February 12, 1998
Polymerase chain reaction-based microsatellite analysis of fine-needle aspirations from Hürthle cell neoplasmsY Takiyama, M Saji, D P Clark, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroidD L Segev, M Saji, G S Phillips, et al.
Gynecologic Oncology|February 2, 2013
Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancerK S Rath, D Loseth, P Muscarella, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 20, 2019
Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective studyD M Barrios, G S Phillips, A Freites-Martinez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2021
IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapiesD M Barrios, G S Phillips, A N Geisler, et al.
Pageof 1